DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 966 filers reported holding DANAHER CORPORATION in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,950,653 | +4.5% | 11,893 | +1.1% | 0.06% | +8.9% |
Q2 2023 | $2,824,320 | -4.4% | 11,768 | +0.4% | 0.06% | -5.1% |
Q1 2023 | $2,953,909 | -23.4% | 11,720 | -19.3% | 0.06% | -24.4% |
Q4 2022 | $3,856,818 | +11.9% | 14,531 | +8.9% | 0.08% | +5.4% |
Q3 2022 | $3,447,000 | -7.2% | 13,344 | -8.9% | 0.07% | 0.0% |
Q2 2022 | $3,713,000 | -13.6% | 14,644 | 0.0% | 0.07% | +4.2% |
Q1 2022 | $4,296,000 | -5.5% | 14,644 | +6.0% | 0.07% | +4.4% |
Q4 2021 | $4,547,000 | +0.4% | 13,819 | -7.1% | 0.07% | -1.4% |
Q3 2021 | $4,527,000 | +4.7% | 14,869 | -7.7% | 0.07% | +6.2% |
Q2 2021 | $4,325,000 | -27.4% | 16,116 | -39.1% | 0.06% | -31.6% |
Q1 2021 | $5,955,000 | +1.3% | 26,458 | 0.0% | 0.10% | -5.0% |
Q4 2020 | $5,877,000 | -12.8% | 26,458 | -15.5% | 0.10% | -24.2% |
Q3 2020 | $6,738,000 | -9.2% | 31,293 | -25.4% | 0.13% | -12.0% |
Q2 2020 | $7,417,000 | +26.4% | 41,943 | -1.0% | 0.15% | +7.9% |
Q1 2020 | $5,866,000 | -11.2% | 42,382 | -1.5% | 0.14% | +18.8% |
Q4 2019 | $6,604,000 | -10.6% | 43,031 | -15.9% | 0.12% | -12.7% |
Q3 2019 | $7,386,000 | -6.3% | 51,142 | -7.3% | 0.13% | -3.6% |
Q2 2019 | $7,886,000 | +2.9% | 55,179 | -4.9% | 0.14% | +0.7% |
Q1 2019 | $7,662,000 | +27.0% | 58,039 | -0.8% | 0.14% | +14.0% |
Q4 2018 | $6,035,000 | -84.5% | 58,524 | -83.7% | 0.12% | -80.4% |
Q3 2018 | $38,906,000 | +4.1% | 358,050 | -5.5% | 0.62% | -1.4% |
Q2 2018 | $37,378,000 | -0.8% | 378,780 | -1.6% | 0.63% | -2.8% |
Q1 2018 | $37,697,000 | +6.2% | 385,015 | +0.6% | 0.64% | +6.8% |
Q4 2017 | $35,508,000 | +8.3% | 382,545 | +0.1% | 0.60% | +5.6% |
Q3 2017 | $32,795,000 | +2.0% | 382,315 | +0.4% | 0.57% | +1.6% |
Q2 2017 | $32,143,000 | +1.5% | 380,885 | +2.9% | 0.56% | -0.2% |
Q1 2017 | $31,655,000 | +9.3% | 370,100 | -0.5% | 0.56% | +3.9% |
Q4 2016 | $28,961,000 | +7.4% | 372,060 | +8.2% | 0.54% | +12.2% |
Q3 2016 | $26,961,000 | -6.2% | 343,935 | +20.8% | 0.48% | -6.9% |
Q2 2016 | $28,746,000 | -1.2% | 284,615 | -7.2% | 0.52% | +4.0% |
Q1 2016 | $29,095,000 | +11.9% | 306,715 | +9.6% | 0.50% | +17.4% |
Q4 2015 | $26,004,000 | +7.0% | 279,970 | -1.8% | 0.43% | +10.4% |
Q3 2015 | $24,295,000 | +159.4% | 285,115 | +160.6% | 0.39% | +203.9% |
Q2 2015 | $9,366,000 | +0.9% | 109,425 | +0.1% | 0.13% | +13.4% |
Q1 2015 | $9,283,000 | -9.4% | 109,340 | -8.5% | 0.11% | -6.7% |
Q4 2014 | $10,242,000 | +8.6% | 119,500 | -3.7% | 0.12% | +11.1% |
Q3 2014 | $9,429,000 | – | 124,100 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |